PMC:3586680 / 817-1027 JSONTXT

Annnotations TAB JSON ListView MergeView

    test3

    {"project":"test3","denotations":[{"id":"T78","span":{"begin":171,"end":174},"obj":"Protein"},{"id":"T77","span":{"begin":128,"end":132},"obj":"Protein"},{"id":"T76","span":{"begin":95,"end":99},"obj":"Protein"},{"id":"T75","span":{"begin":42,"end":45},"obj":"Protein"},{"id":"T58","span":{"begin":171,"end":174},"obj":"Protein"},{"id":"T57","span":{"begin":128,"end":132},"obj":"Protein"},{"id":"T56","span":{"begin":95,"end":99},"obj":"Protein"},{"id":"T55","span":{"begin":42,"end":45},"obj":"Protein"}],"text":"ntial scenarios that wild type and mutant p53, or isoforms, modulate the apoptotic function of WWOX. We propose that triggering WWOX activation by therapeutic drugs under p53 functional deficiency is needed to "}

    testone

    {"project":"testone","denotations":[{"id":"T36","span":{"begin":171,"end":174},"obj":"Protein"},{"id":"T35","span":{"begin":128,"end":132},"obj":"Protein"},{"id":"T34","span":{"begin":95,"end":99},"obj":"Protein"},{"id":"T33","span":{"begin":42,"end":45},"obj":"Protein"}],"text":"ntial scenarios that wild type and mutant p53, or isoforms, modulate the apoptotic function of WWOX. We propose that triggering WWOX activation by therapeutic drugs under p53 functional deficiency is needed to "}

    bionlp-st-ge-2016-test-tees

    {"project":"bionlp-st-ge-2016-test-tees","denotations":[{"id":"T496","span":{"begin":186,"end":196},"obj":"Negative_regulation"},{"id":"T495","span":{"begin":171,"end":174},"obj":"Protein"},{"id":"T494","span":{"begin":60,"end":68},"obj":"Regulation"},{"id":"T493","span":{"begin":95,"end":99},"obj":"Protein"},{"id":"T492","span":{"begin":42,"end":45},"obj":"Protein"}],"relations":[{"id":"R246","pred":"causeOf","subj":"T492","obj":"T494"},{"id":"R247","pred":"themeOf","subj":"T493","obj":"T494"},{"id":"R248","pred":"themeOf","subj":"T495","obj":"T496"}],"text":"ntial scenarios that wild type and mutant p53, or isoforms, modulate the apoptotic function of WWOX. We propose that triggering WWOX activation by therapeutic drugs under p53 functional deficiency is needed to "}

    bionlp-st-ge-2016-spacy-parsed

    {"project":"bionlp-st-ge-2016-spacy-parsed","denotations":[{"id":"T720","span":{"begin":207,"end":209},"obj":"TO"},{"id":"T719","span":{"begin":200,"end":206},"obj":"VBN"},{"id":"T718","span":{"begin":197,"end":199},"obj":"VBZ"},{"id":"T717","span":{"begin":186,"end":196},"obj":"NN"},{"id":"T716","span":{"begin":175,"end":185},"obj":"JJ"},{"id":"T715","span":{"begin":171,"end":174},"obj":"NN"},{"id":"T713","span":{"begin":159,"end":164},"obj":"NNS"},{"id":"T712","span":{"begin":147,"end":158},"obj":"JJ"},{"id":"T711","span":{"begin":144,"end":146},"obj":"IN"},{"id":"T710","span":{"begin":133,"end":143},"obj":"NN"},{"id":"T709","span":{"begin":128,"end":132},"obj":"NNP"},{"id":"T708","span":{"begin":117,"end":127},"obj":"VBG"},{"id":"T707","span":{"begin":112,"end":116},"obj":"IN"},{"id":"T706","span":{"begin":104,"end":111},"obj":"VBP"},{"id":"T705","span":{"begin":101,"end":103},"obj":"PRP"},{"id":"T704","span":{"begin":99,"end":100},"obj":"."},{"id":"T703","span":{"begin":95,"end":99},"obj":"NNP"},{"id":"T702","span":{"begin":92,"end":94},"obj":"IN"},{"id":"T701","span":{"begin":83,"end":91},"obj":"NN"},{"id":"T700","span":{"begin":73,"end":82},"obj":"JJ"},{"id":"T699","span":{"begin":69,"end":72},"obj":"DT"},{"id":"T698","span":{"begin":60,"end":68},"obj":"VBP"},{"id":"T697","span":{"begin":58,"end":59},"obj":","},{"id":"T696","span":{"begin":50,"end":58},"obj":"NNS"},{"id":"T695","span":{"begin":47,"end":49},"obj":"CC"},{"id":"T694","span":{"begin":45,"end":46},"obj":","},{"id":"T693","span":{"begin":42,"end":45},"obj":"NN"},{"id":"T692","span":{"begin":35,"end":41},"obj":"JJ"},{"id":"T691","span":{"begin":31,"end":34},"obj":"CC"},{"id":"T690","span":{"begin":26,"end":30},"obj":"NN"},{"id":"T689","span":{"begin":21,"end":25},"obj":"JJ"},{"id":"T688","span":{"begin":16,"end":20},"obj":"WDT"},{"id":"T687","span":{"begin":6,"end":15},"obj":"NNS"},{"id":"T714","span":{"begin":165,"end":170},"obj":"IN"}],"relations":[{"id":"R400","pred":"nsubj","subj":"T688","obj":"T698"},{"id":"R401","pred":"amod","subj":"T689","obj":"T690"},{"id":"R402","pred":"nsubj","subj":"T690","obj":"T698"},{"id":"R403","pred":"cc","subj":"T691","obj":"T690"},{"id":"R404","pred":"amod","subj":"T692","obj":"T693"},{"id":"R405","pred":"conj","subj":"T693","obj":"T690"},{"id":"R406","pred":"punct","subj":"T694","obj":"T693"},{"id":"R407","pred":"cc","subj":"T695","obj":"T693"},{"id":"R408","pred":"conj","subj":"T696","obj":"T693"},{"id":"R409","pred":"punct","subj":"T697","obj":"T698"},{"id":"R410","pred":"relcl","subj":"T698","obj":"T687"},{"id":"R411","pred":"det","subj":"T699","obj":"T701"},{"id":"R412","pred":"amod","subj":"T700","obj":"T701"},{"id":"R413","pred":"dobj","subj":"T701","obj":"T698"},{"id":"R414","pred":"prep","subj":"T702","obj":"T701"},{"id":"R415","pred":"pobj","subj":"T703","obj":"T702"},{"id":"R417","pred":"nsubj","subj":"T705","obj":"T706"},{"id":"R418","pred":"ROOT","subj":"T706","obj":"T706"},{"id":"R419","pred":"mark","subj":"T707","obj":"T719"},{"id":"R420","pred":"csubj","subj":"T708","obj":"T719"},{"id":"R421","pred":"compound","subj":"T709","obj":"T710"},{"id":"R422","pred":"dobj","subj":"T710","obj":"T708"},{"id":"R423","pred":"prep","subj":"T711","obj":"T710"},{"id":"R424","pred":"amod","subj":"T712","obj":"T713"},{"id":"R425","pred":"pobj","subj":"T713","obj":"T711"},{"id":"R426","pred":"amod","subj":"T715","obj":"T717"},{"id":"R427","pred":"amod","subj":"T716","obj":"T717"},{"id":"R428","pred":"pobj","subj":"T717","obj":"T714"},{"id":"R429","pred":"auxpass","subj":"T718","obj":"T719"},{"id":"R430","pred":"ccomp","subj":"T719","obj":"T706"},{"id":"R443","pred":"prep","subj":"T714","obj":"T710"}],"text":"ntial scenarios that wild type and mutant p53, or isoforms, modulate the apoptotic function of WWOX. We propose that triggering WWOX activation by therapeutic drugs under p53 functional deficiency is needed to "}

    bionlp-st-ge-2016-test-ihmc

    {"project":"bionlp-st-ge-2016-test-ihmc","denotations":[{"id":"T548","span":{"begin":128,"end":143},"obj":"Positive_regulation"},{"id":"T545","span":{"begin":128,"end":132},"obj":"Protein"},{"id":"T542","span":{"begin":147,"end":164},"obj":"Entity"},{"id":"T536","span":{"begin":171,"end":174},"obj":"Protein"},{"id":"T530","span":{"begin":92,"end":99},"obj":"Protein"},{"id":"T528","span":{"begin":35,"end":59},"obj":"Protein"}],"relations":[{"id":"R264","pred":"themeOf","subj":"T545","obj":"T548"}],"text":"ntial scenarios that wild type and mutant p53, or isoforms, modulate the apoptotic function of WWOX. We propose that triggering WWOX activation by therapeutic drugs under p53 functional deficiency is needed to "}

    DLUT931

    {"project":"DLUT931","denotations":[{"id":"T424","span":{"begin":117,"end":127},"obj":"Positive_regulation"},{"id":"T423","span":{"begin":186,"end":196},"obj":"Negative_regulation"},{"id":"T422","span":{"begin":133,"end":143},"obj":"Positive_regulation"},{"id":"T421","span":{"begin":60,"end":68},"obj":"Regulation"},{"id":"T414","span":{"begin":171,"end":174},"obj":"Protein"},{"id":"T413","span":{"begin":128,"end":132},"obj":"Protein"},{"id":"T412","span":{"begin":95,"end":99},"obj":"Protein"},{"id":"T411","span":{"begin":42,"end":45},"obj":"Protein"}],"relations":[{"id":"R218","pred":"causeOf","subj":"T411","obj":"T421"},{"id":"R219","pred":"themeOf","subj":"T412","obj":"T421"},{"id":"R220","pred":"themeOf","subj":"T413","obj":"T422"},{"id":"R221","pred":"themeOf","subj":"T414","obj":"T423"},{"id":"R224","pred":"themeOf","subj":"T422","obj":"T424"},{"id":"R225","pred":"causeOf","subj":"T423","obj":"T424"}],"text":"ntial scenarios that wild type and mutant p53, or isoforms, modulate the apoptotic function of WWOX. We propose that triggering WWOX activation by therapeutic drugs under p53 functional deficiency is needed to "}

    BioNLP16_Messiy

    {"project":"BioNLP16_Messiy","denotations":[{"id":"T473","span":{"begin":133,"end":143},"obj":"Positive_regulation"},{"id":"T472","span":{"begin":117,"end":127},"obj":"Positive_regulation"},{"id":"T471","span":{"begin":186,"end":196},"obj":"Negative_regulation"},{"id":"T464","span":{"begin":171,"end":174},"obj":"Protein"},{"id":"T463","span":{"begin":128,"end":132},"obj":"Protein"},{"id":"T462","span":{"begin":95,"end":99},"obj":"Protein"},{"id":"T461","span":{"begin":42,"end":45},"obj":"Protein"}],"relations":[{"id":"R234","pred":"themeOf","subj":"T463","obj":"T473"},{"id":"R235","pred":"themeOf","subj":"T464","obj":"T471"},{"id":"R238","pred":"themeOf","subj":"T473","obj":"T472"}],"text":"ntial scenarios that wild type and mutant p53, or isoforms, modulate the apoptotic function of WWOX. We propose that triggering WWOX activation by therapeutic drugs under p53 functional deficiency is needed to "}

    BioNLP16_DUT

    {"project":"BioNLP16_DUT","denotations":[{"id":"T380","span":{"begin":117,"end":127},"obj":"Positive_regulation"},{"id":"T379","span":{"begin":133,"end":143},"obj":"Positive_regulation"},{"id":"T378","span":{"begin":186,"end":196},"obj":"Negative_regulation"},{"id":"T372","span":{"begin":171,"end":174},"obj":"Protein"},{"id":"T371","span":{"begin":128,"end":132},"obj":"Protein"},{"id":"T370","span":{"begin":95,"end":99},"obj":"Protein"},{"id":"T369","span":{"begin":42,"end":45},"obj":"Protein"}],"relations":[{"id":"R208","pred":"themeOf","subj":"T371","obj":"T379"},{"id":"R209","pred":"themeOf","subj":"T372","obj":"T378"},{"id":"R211","pred":"themeOf","subj":"T379","obj":"T380"}],"text":"ntial scenarios that wild type and mutant p53, or isoforms, modulate the apoptotic function of WWOX. We propose that triggering WWOX activation by therapeutic drugs under p53 functional deficiency is needed to "}

    bionlp-st-ge-2016-uniprot

    {"project":"bionlp-st-ge-2016-uniprot","denotations":[{"id":"T395","span":{"begin":42,"end":45},"obj":"http://www.uniprot.org/uniprot/P04637"},{"id":"T387","span":{"begin":95,"end":99},"obj":"http://www.uniprot.org/uniprot/Q9NZC7"}],"namespaces":[{"prefix":"_base","uri":"http://www.uniprot.org/uniprot/"}],"text":"ntial scenarios that wild type and mutant p53, or isoforms, modulate the apoptotic function of WWOX. We propose that triggering WWOX activation by therapeutic drugs under p53 functional deficiency is needed to "}

    bionlp-st-ge-2016-test-proteins

    {"project":"bionlp-st-ge-2016-test-proteins","denotations":[{"id":"T132","span":{"begin":42,"end":45},"obj":"Protein"},{"id":"T133","span":{"begin":95,"end":99},"obj":"Protein"},{"id":"T134","span":{"begin":128,"end":132},"obj":"Protein"},{"id":"T135","span":{"begin":171,"end":174},"obj":"Protein"}],"namespaces":[{"prefix":"_base","uri":"http://bionlp.dbcls.jp/ontology/ge.owl#"}],"text":"ntial scenarios that wild type and mutant p53, or isoforms, modulate the apoptotic function of WWOX. We propose that triggering WWOX activation by therapeutic drugs under p53 functional deficiency is needed to "}

    pmc-enju-pas

    {"project":"pmc-enju-pas","denotations":[{"id":"T328","span":{"begin":207,"end":209},"obj":"TO"},{"id":"T327","span":{"begin":200,"end":206},"obj":"VB"},{"id":"T326","span":{"begin":197,"end":199},"obj":"VB"},{"id":"T325","span":{"begin":186,"end":196},"obj":"NN"},{"id":"T324","span":{"begin":175,"end":185},"obj":"JJ"},{"id":"T323","span":{"begin":171,"end":174},"obj":"NN"},{"id":"T322","span":{"begin":165,"end":170},"obj":"IN"},{"id":"T321","span":{"begin":159,"end":164},"obj":"NN"},{"id":"T320","span":{"begin":147,"end":158},"obj":"JJ"},{"id":"T319","span":{"begin":144,"end":146},"obj":"IN"},{"id":"T318","span":{"begin":133,"end":143},"obj":"NN"},{"id":"T317","span":{"begin":128,"end":132},"obj":"NN"},{"id":"T316","span":{"begin":117,"end":127},"obj":"VB"},{"id":"T315","span":{"begin":112,"end":116},"obj":"IN"},{"id":"T314","span":{"begin":104,"end":111},"obj":"VB"},{"id":"T313","span":{"begin":101,"end":103},"obj":"PRP"},{"id":"T312","span":{"begin":95,"end":99},"obj":"NN"},{"id":"T311","span":{"begin":92,"end":94},"obj":"IN"},{"id":"T310","span":{"begin":83,"end":91},"obj":"NN"},{"id":"T309","span":{"begin":73,"end":82},"obj":"JJ"},{"id":"T308","span":{"begin":69,"end":72},"obj":"DT"},{"id":"T307","span":{"begin":60,"end":68},"obj":"VB"},{"id":"T306","span":{"begin":58,"end":59},"obj":"-COMMA-"},{"id":"T305","span":{"begin":50,"end":58},"obj":"NN"},{"id":"T304","span":{"begin":47,"end":49},"obj":"CC"},{"id":"T303","span":{"begin":45,"end":46},"obj":"-COMMA-"},{"id":"T302","span":{"begin":42,"end":45},"obj":"NN"},{"id":"T301","span":{"begin":35,"end":41},"obj":"JJ"},{"id":"T300","span":{"begin":31,"end":34},"obj":"CC"},{"id":"T299","span":{"begin":26,"end":30},"obj":"NN"},{"id":"T298","span":{"begin":21,"end":25},"obj":"JJ"},{"id":"T297","span":{"begin":16,"end":20},"obj":"IN"},{"id":"T296","span":{"begin":6,"end":15},"obj":"NN"}],"relations":[{"id":"R163","pred":"arg1Of","subj":"T296","obj":"T297"},{"id":"R164","pred":"arg1Of","subj":"T299","obj":"T298"},{"id":"R165","pred":"arg1Of","subj":"T299","obj":"T300"},{"id":"R166","pred":"arg1Of","subj":"T300","obj":"T304"},{"id":"R167","pred":"arg2Of","subj":"T302","obj":"T300"},{"id":"R168","pred":"arg1Of","subj":"T302","obj":"T301"},{"id":"R169","pred":"arg1Of","subj":"T304","obj":"T303"},{"id":"R170","pred":"arg1Of","subj":"T304","obj":"T307"},{"id":"R171","pred":"arg2Of","subj":"T305","obj":"T304"},{"id":"R172","pred":"arg2Of","subj":"T307","obj":"T297"},{"id":"R173","pred":"arg1Of","subj":"T307","obj":"T306"},{"id":"R174","pred":"arg2Of","subj":"T310","obj":"T307"},{"id":"R175","pred":"arg1Of","subj":"T310","obj":"T308"},{"id":"R176","pred":"arg1Of","subj":"T310","obj":"T309"},{"id":"R177","pred":"arg1Of","subj":"T310","obj":"T311"},{"id":"R178","pred":"arg2Of","subj":"T312","obj":"T311"},{"id":"R179","pred":"arg1Of","subj":"T313","obj":"T314"},{"id":"R180","pred":"arg1Of","subj":"T318","obj":"T316"},{"id":"R181","pred":"arg1Of","subj":"T318","obj":"T317"},{"id":"R182","pred":"arg1Of","subj":"T318","obj":"T319"},{"id":"R183","pred":"arg1Of","subj":"T318","obj":"T322"},{"id":"R184","pred":"arg1Of","subj":"T318","obj":"T326"},{"id":"R185","pred":"arg2Of","subj":"T318","obj":"T327"},{"id":"R186","pred":"arg2Of","subj":"T321","obj":"T319"},{"id":"R187","pred":"arg1Of","subj":"T321","obj":"T320"},{"id":"R188","pred":"arg2Of","subj":"T325","obj":"T322"},{"id":"R189","pred":"arg1Of","subj":"T325","obj":"T323"},{"id":"R190","pred":"arg1Of","subj":"T325","obj":"T324"},{"id":"R191","pred":"arg2Of","subj":"T327","obj":"T314"},{"id":"R192","pred":"arg1Of","subj":"T327","obj":"T315"},{"id":"R193","pred":"arg2Of","subj":"T327","obj":"T326"},{"id":"R194","pred":"modOf","subj":"T327","obj":"T328"}],"namespaces":[{"prefix":"_base","uri":"http://kmcs.nii.ac.jp/enju/"}],"text":"ntial scenarios that wild type and mutant p53, or isoforms, modulate the apoptotic function of WWOX. We propose that triggering WWOX activation by therapeutic drugs under p53 functional deficiency is needed to "}

    simple1

    {"project":"simple1","denotations":[{"id":"T165","span":{"begin":171,"end":174},"obj":"Protein"},{"id":"T164","span":{"begin":128,"end":132},"obj":"Protein"},{"id":"T163","span":{"begin":95,"end":99},"obj":"Protein"},{"id":"T162","span":{"begin":42,"end":45},"obj":"Protein"}],"text":"ntial scenarios that wild type and mutant p53, or isoforms, modulate the apoptotic function of WWOX. We propose that triggering WWOX activation by therapeutic drugs under p53 functional deficiency is needed to "}